TERADATA CORP /DE/
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Company Common Stock
From time to time, the Company's Section 16 officers sell to the Company shares of the Company's common stock received upon vesting of restricted share units at the current market price to cover their withholding tax obligations. For the nine months ended September 30, 2025, the total of these purchases was 276,578 shares at an average price of $24.22 per share.
The following table provides information relating to the Company’s share repurchase programs for the nine months ended September 30, 2025:
| TotalNumberof Shares Purchased | AveragePricePaidper Share | TotalNumberof SharesPurchasedas Part ofPubliclyAnnouncedDilutionOffset Program (1) | TotalNumberof SharesPurchasedas Part ofPubliclyAnnouncedOpen Market ShareRepurchase Program (2) | MaximumDollarValuethat MayYet BePurchasedUnder theDilutionOffset Program | MaximumDollarValuethat MayYet BePurchasedUnder theOpen Market ShareRepurchase Program | |
|---|---|---|---|---|---|---|
| Month | ||||||
| January 2025 | 634,872 | $31.50 | — | 634,872 | $442,485 | $331,609,730 |
| February 2025 | 514,547 | $27.39 | 19,405 | 495,142 | $16,209 | $317,969,936 |
| March 2025 | 413,828 | $23.09 | 218,758 | 195,070 | $101,574 | $313,419,831 |
| First Quarter Total | 1,563,247 | $27.92 | 238,163 | 1,325,084 | $101,574 | $313,419,831 |
| April 2025 | 458,523 | $20.84 | — | 458,523 | $101,574 | $303,865,062 |
| May 2025 | 426,561 | $22.40 | — | 426,561 | $101,574 | $294,310,306 |
| June 2025 | 412,224 | $22.07 | — | 412,224 | $101,574 | $285,210,524 |
| Second Quarter Total | 1,297,308 | $21.74 | — | 1,297,308 | $101,574 | $285,210,524 |
| July 2025 | 451,179 | $22.19 | — | 451,179 | $101,574 | 275,200,814 |
| August 2025 | 457,139 | $20.90 | — | 457,139 | $101,574 | 265,647,969 |
| September 2025 | 516,254 | $21.60 | 222,887 | 293,367 | $124,167 | 259,180,240 |
| Third Quarter Total | 1,424,572 | $21.56 | 222,887 | 1,201,685 | $124,167 | $259,180,240 |
(1) The dilution offset share repurchase program allows the Company to repurchase Teradata common stock to the extent of cash received from the exercise of stock options and purchases under the ESPP to offset dilution from shares issued pursuant to these plans.
(2) The open market share repurchase program authorized by the Board allows the Company to repurchase outstanding shares of Teradata common stock. Share repurchases made by the Company are reported on a trade date basis. The open market share repurchase program expires on December 31, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.